Corvus Pharmaceuticals, Inc. (CRVS): Price and Financial Metrics
CRVS Price/Volume Stats
| Current price | $5.01 | 52-week high | $10.00 |
| Prev. close | $4.73 | 52-week low | $1.30 |
| Day low | $4.66 | Volume | 719,200 |
| Day high | $5.12 | Avg. volume | 682,755 |
| 50-day MA | $7.17 | Dividend yield | N/A |
| 200-day MA | $4.40 | Market Cap | 321.93M |
CRVS Stock Price Chart Interactive Chart >
Corvus Pharmaceuticals, Inc. (CRVS) Company Bio
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of small molecule and antibody agents that target the immune system to treat patients with cancer. The company was founded in 2014 and is based in Burlingame, California.
CRVS Price Returns
| 1-mo | 0.40% |
| 3-mo | -33.73% |
| 6-mo | 116.88% |
| 1-year | 144.39% |
| 3-year | 183.05% |
| 5-year | -15.51% |
| YTD | -6.36% |
| 2024 | 203.98% |
| 2023 | 107.06% |
| 2022 | -64.73% |
| 2021 | -32.30% |
| 2020 | -34.56% |
Loading social stream, please wait...